The Superior Court of California for the District of Los Angeles has granted Byetta plaintiffs’ motion to unseal images from a 273-day monkey study conducted by Amylin Pharmaceuticals, a subsidiary of AstraZeneca. According to a court document, the ruling was made at a July 9 status conference.
Byetta is a widely prescribed type 2 diabetes medication belonging to the incretin mimetic class of drugs. Despite its popularity, Byetta has been the ...
continue reading...
When we think about clinical trials we think about sterile rooms filled with people wearing white coats and carrying tablet computers. Sometimes it’s hard to remember that there are patients on the other side of those trials – patients who want nothing more than for the trial to go well.
In some cases, these clinical trials can lead to breakthroughs that change the face of medicine forever. In others, ...
continue reading...
After a number of states expanded their Medicaid eligibility to include low-income adults, the number of new diabetes diagnoses also increased. A study in Diabetes Care talks about how expansion of Medicaid eligibility has had a big effect on the availability of healthcare to patients in vulnerable populations. Modern Healthcare recently detailed the study and some other possible results of the care expansion.
According to the study, ...
continue reading...
Pfizer Chief Executive Ian Read’s total pay rose 23 percent last year, a Wall Street Journal article reports. Read’s total pay package for 2014 was $23.3 million. The pay increase comes after Pfizer’s board declared Read’s leadership last year to be “outstanding.”
Despite the board’s praise, 2014 was hardly a trouble-free year for the New York–based company. As in previous years, Lipitor lawsuits continued to accumulate against Pfizer. ...
continue reading...
A new report by the United States Centers for Disease Control and Prevention (CDC) found that one in every ten U.S. doctor visits involved diabetes by the year 2010. The research “demonstrates that diabetes is no longer a disease of older patients” and shows a large increase in the number of doctor’s office visits for young adults. The study also examined the number of medications and chronic conditions in various age brackets.
There are about 29 ...
continue reading...New data from the Centers for Disease Control and Prevention (CDC) shows a dramatic increase in the percentage of Americans who are predicted to develop diabetes at some point in their lives. An article by HealthDay News reports the findings of the CDC study that were published August 13, 2014 in The Lancet Diabetes & Endocrinology.
The majority of the people with diabetes have Type II, wherein the body either does not produce enough insulin or is resistant ...
continue reading...
